As RCTs were conducted in homogenous cancer populations, such as histopathological subtypes, positive and negative PD-L1 cohorts, ICI in monotherapy, or plus ChT, the current study included all treated mNSCLC patients in a specific period of time, leading to a more heterogenous patient population. The gene discussed is CD274; the disease is cancer.